진통제 주입 펌프 시장 : 제품별, 용도별, 지역별(2024-2031년)

Analgesic Infusion Pumps Market-Valuation-2024-2031

The Analgesic Infusion Pumps Market size was valued at USD 2.75 Billion in 2023. The Infusion Pump is a commonly used medical device for patients with chronic conditions like cancer and diabetes to overcome delivery-related problems.

The increasing prevalence of chronic pain among the elderly, a growing demand for pain management during surgical procedures, and a rising number of surgeries performed worldwide is thereby surging demand for analgesic infusion pumps. Thus, the current market will grow at a (CAGR) of around 5.3% from 2024 to 2031, reaching a market size of worthUSD 3.05 Billion by 2031.

Analgesic Infusion Pumps Market: Definition/Overview

Analgesic infusion pumps are medical devices designed to deliver pain-relieving medications directly into a patient's body. By providing a constant and precise flow of analgesics, these pumps can effectively manage pain and improve the quality of life for patients. These solutions are particularly useful in obstetric, terminally ill, postoperative, and trauma patients. The pumps can be programmed to deliver a specific dosage over a set of periods, ensuring a steady release of pain relief medication.

The increasing prevalence of chronic pain conditions such as failed back syndrome, complex regional pain syndrome (CRPS), myocardial infarction, spinal cord injury, cerebral palsy, and others, among all age groups, especially the geriatric population, is increasing demand for pain management treatments such as analgesic fusion pumps.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Which are the Drivers Encouraging Adoption of Infusion Pumps?

The prevalence of chronic pain ailments like arthritis, cancer pain, and neuropathic pain across the world among the obese, aged, or other age groups are demanding pain management options, driving demand for analgesic infusion pumps. Likewise, the demand for pain-relieving drug infusers post-surgical procedures is creating room for the Analgesic Infusion Pumps Market.

Also, continuous advancements such as precise dosage control, and remote monitoring, is all possible using smart features such as artificial intelligence, and connected health platforms to help develop a portable and user-friendly solution. Thus, the improvements in pump technology are enhancing the capabilities and user experience of analgesic infusion pumps.

Moreover, the application of effective pain management solutions such as these pumps is increasing owing to initiatives and educational campaigns offering therapeutic benefits and patient satisfaction. Awareness regarding the use of analgesic infusion pumps in home-based care and ambulatory surgical centers is increasing to shorten hospital stays and personalize pain management.

Besides these, high disposable incomes in developing economies is improving accessibility to healthcare services and advanced medical technologies like analgesic infusion pumps, driving their sales.

Despite their high costs and regulatory hurdles, the advantages of the Analgesic Infusion Pumps Market is projected to continue growing in the coming years.

Will High Costs Hinder Growth of the Analgesic Infusion Pumps Market?

The cost of development and maintenance of technologically advanced infusion pumps can be affect the adoption rate by healthcare facilities, particularly those in resource-limited or lower-income settings. This limits their ability to invest in these devices as the needle and syringe used will further add up to the overall cost, potentially hindering patient access to advanced treatment options.

The existence of stringent regulatory requirements for medical devices is likely to extend the approval and expense of the development processes, delaying market entry. This financial expense is likely to burden the manufacturers and healthcare providers.

While pumps offer advantages in some scenarios, convincing healthcare professionals and patients is challenging as alternative pain management options, like oral medications, non-invasive techniques like nerve blocks, and physical therapy are proving effective.

Also, the need for proper training is necessary to avoid human error, which is likely to cause over or underdosing. These risks are majorly impacting the sales of Analgesic Infusion Pumps Market.

The technical limitations such integration with the existing healthcare systems or connective device is complex, expensive, and prone to cyberthreats. Such technological errors along with compatibility issues plummet the adoption rate to a greater extent.

Category- Wise Acumens

Which Product Category Dominates the Analgesic Infusion Pumps Market?

The increasing prevalence of chronic diseases among all age groups, especially aged group, is demanding need for comfortable and self-administer treatment options, thereby bolstering the use of patient-controlled analgesia pumps. This demand is likely to help fuel the global market size. Healthcare professionals are increasing the demand for patient-controlled analgesia pumps to manage patients' post-operative pain, chronic pain management, and labor analgesia.

The adoption of portable patient-controlled analgesia pumps for home healthcare is driving the global market trend. Patients rising preference for these devices owing to its cost-effectiveness compared to other types of pumps is propelling the market. Its role in reducing hospital stays is enables cost-savings as well as remote monitoring. Thus, healthcare manufacturers are their focus on patient-controlled analgesic pumps in compliance with regulatory standards and industrial standards.

Furthermore, the integration of AI, MI, Internet of Things (IoT), and other advanced technologies will modernize these drug delivery systems to an extent offering safety, efficiency, remote monitoring, and accuracy.

Which Factors are Influencing the Growth of Home Care Industry?

As per Verified Market Research, home care segment is projected to experience fastest-growth over the forecast period. There is an increasing demand for patient-centric care and personalized treatment options, creating wider scope of adoption of integration of remote monitoring and telehealth capabilities in analgesic infusion pumps.

Also, a growing preference for familiar and comfortable environments for treatment among the elderly or disease-affected patients is driving the need for home-based medical devices. The high prevalence of chronic illness with acute pain such as cancer, neurological disorder, and arthritis leads to non-pocket-friendly outcomes, thereby encouraging the use of cost-effective chronic pain management or value-based care at home compared to extended hospital stays

The COVID-19 pandemic has accelerated the adoption of home care services as hospitals faced capacity challenges and patients sought to minimize exposure to the virus. The pandemic has reinforced the importance of home-based healthcare, including the use of analgesic infusion pumps.

Country/Region-wise Acumens

What Factors Enable North America Hold Major Share in Analgesic Infusion Pumps Market?

Growing adoption of a sedentary lifestyle, changing dietary habits, and geographical conditions are increasing incidences of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. This creates a substantial market for pain management solutions like analgesic infusion pumps. Primarily, the focus on ensuring whether analgesic infusion pumps meet rigorous safety and efficacy standards before being introduced into the market and fostering trust among healthcare professionals and patients are factors bolstering the demand in North America.

Additionally, the aging population with higher susceptibility to chronic illnesses in North America is leading to a higher demand for healthcare services, including pain management. Thereby, the demand for pain treatment options is creating lucrative opportunities for analgesic infusion pumps in this region.

The region has well-established distribution networks and efficient supply chains for medical devices. This facilitates the easy availability and accessibility of analgesic infusion pumps across healthcare institutions. High levels of healthcare spending is also contributing to the adoption of advanced medical technologies, including analgesic infusion pumps, to improve patient care and outcomes. The advancements in pain management solutions are enabling North America to retain its dominance in the Analgesic Infusion Pumps Market.

How will Surging Demand for Advanced Medical Technologies Affect the Analgesic Infusion Pumps Market in Asia Pacific?

The demand for advanced medical technologies often goes hand-in-hand with an increased awareness and understanding of these technologies among healthcare professionals and patients. This may lead to adoption of analgesic infusion pumps as healthcare providers become more educated about their benefits in managing pain effectively. In response to this technological demand, the market enables Asia Pacific to experience substantial growth over the forecast period.

The rising demand for advanced medical technologies is driving support and investment from government authorities in the research and development in the field of analgesic infusion pumps. This may result in the development of more sophisticated and user-friendly devices with enhanced features, improved safety profiles, and greater precision in drug delivery in the region. Similarly, increasing spending on healthcare by the governments and private healthcare providers in the Asia Pacific is creating opportunities for the growth of the Analgesic Infusion Pumps Market.

The growing demand for analgesic infusion pumps is attracting both local and international manufacturers to the Asia Pacific market. This increased competition may lead to the development of new and improved analgesic infusion pumps with features, such as remote monitoring, bolus dosing, and integration with electronic health records, increasing accessibility, cost-effectiveness, and quality, and ultimately benefiting healthcare providers and patients.

Competitive Landscape

The Analgesic Infusion Pumps Market is intensely competitive, fueled by rapid technological breakthroughs and rising demand for effective pain management solutions. Market competitors are constantly striving to improve the efficiency, safety, and overall performance of infusion pumps to satisfy the changing needs, resulting in a dynamic and competitive environment within the sector.

Some of the prominent players operating in the Analgesic Infusion Pumps Market include:

Medtronic plc, Becton Dickinson and Company (BD), Braun Melsungen AG, Fresenius Kabi AG, Smith's Medical, Terumo Corporation, ICU Medical Inc., Roche Diagnostics (AccuVein), Moog Inc., Animas Corporation, Tandem Diabetes Care Inc., Micrel Medical Devices S.A. (a Mindray Company), Zyno Medical, Sensile Medical AG (a subsidiary of Gerresheimer AG), CME Medical (a BD Company), Zenith Medic (a subsidiary of Smiths Group), Q Core Medical Ltd., Ace Medical Co. Ltd., Nipro Corporation, Chemyx Inc.

Latest Developments

In August 2023, ICU Medical, Inc. (US) received FDA clearance for its Plum Duo infusion Pump, which make it available for customers in the US in early 2024.

In April 2023, Fresenius Kabi (Germany) announced that its Ivenix Infusion System has received on Innovative Technology contract from Vizient, Inc. (US), which sets terms for hospitals to evaluate and purchase the Ivenix Infusion System.

In August 2022, Becton Dickinson and company (Us) Novum IQ Syringe Infusion Pump received FDA Approval.

In March 2022, Fresenius Kabi (Germany) received US FDA approval for the wireless Agilia Connect Infusion System, which includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med Technology.

TABLE OF CONTENTS

1. INTRODUCTION OF GLOBAL ANALGESIC INFUSION PUMPS MARKET

• 1.1. Overview of the Market
• 1.2. Scope of Report
• 1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1. Data Mining
• 3.2. Validation
• 3.3. Primary Interviews
• 3.4. List of Data Sources

4. GLOBAL ANALGESIC INFUSION PUMPS MARKET OUTLOOK

• 4.1. Overview
• 4.2. Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunities
• 4.3. Porters Five Force Model

5. GLOBAL ANALGESIC INFUSION PUMPS MARKET, BY PRODUCT

• 5.1. Overview
• 5.2 Epidural Pumps
• 5.3 Intrathecal Pumps
• 5.4 Patient-Controlled Analgesia Pump (PCA)
• 5.5 Others

6. GLOBAL ANALGESIC INFUSION PUMPS MARKET, BY APPLICATION

• 6.1. Overview
• 6.2 Hospitals
• 6.3 Home Care
• 6.4 Ambulatory Surgical Centers

7. GLOBAL ANALGESIC INFUSION PUMPS MARKET, BY GEOGRAPHY

• 7.1. Overview
• 7.2. North America
  • 7.2.1. U.S.
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. Europe
  • 7.3.1. Germany
  • 7.3.2. U.K.
  • 7.3.3. France
  • 7.3.4. Rest of Europe
• 7.4. Asia Pacific
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. India
  • 7.4.4. Rest of Asia Pacific
• 7.5. Rest of the World
  • 7.5.1. Latin America
  • 7.5.2. Middle East & Africa

8. GLOBAL ANALGESIC INFUSION PUMPS MARKET COMPETITIVE LANDSCAPE

• 8.1. Overview
• 8.2. Company Market Ranking
• 8.3. Key Development Strategies

9. COMPANY PROFILES

• 9.1. Medtronic plc
  • 9.1.1. Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Outlook
  • 9.1.4. Key Developments
• 9.2. Becton Dickinson and Company (BD)
  • 9.2.1. Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Outlook
  • 9.2.4. Key Developments
• 9.3. Braun Melsungen AG
  • 9.3.1. Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Outlook
  • 9.3.4. Key Developments
• 9.4. Fresenius Kabi AG
  • 9.4.1. Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Outlook
  • 9.4.4. Key Developments
• 9.5. Smith's Medical
  • 9.5.1. Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Outlook
  • 9.5.4. Key Developments
• 9.6. Terumo Corporation
  • 9.6.1. Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Outlook
  • 9.6.4. Key Developments
• 9.7. ICU Medical Inc.
  • 9.7.1. Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Outlook
  • 9.7.4. Key Developments
• 9.8. Roche Diagnostics (AccuVein)
  • 9.8.1. Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Outlook
  • 9.8.4. Key Developments
• 9.9. Moog Inc.
  • 9.9.1. Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Outlook
  • 9.9.4. Key Developments
• 9.10. Animas Corporation
  • 9.10.1. Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Outlook
  • 9.10.4. Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11. Appendix

• 11.1. Related Research